Feed ORCHPHARMA.NS
OR
Orchid Pharma Limited
ORCHPHARMA.NS · NSE
₹981.35 +1.25% (+₹12.15)
1M -7.40%
Market Cap ₹49.5B
P/E Ratio 243.41x
Div. Yield -
ROE 1.60%
Bulios Fair Price
₹609.71
37.9% downside
Preț actual
₹981.35
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile ORCHPHARMA.NS sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Moderate
4/9Valuation
12 /100
Expensive EV/EBITDA 85.86x
P/S 6.11x
P/B 3.85x
Growth
38 /100
Stable Rev. growth 6.81%
Book val. growth 23.20%
EPS growth 29.07%
Profitability
23 /100
Weak Net margin 2.51%
Op. margin 5.44%
FCF margin 18.15%
Quality
12 /100
Poor ROE 1.60%
ROA 1.07%
Asset turnover 0.42x
Debt
50 /100
Moderate Current ratio 2.45x
Int. coverage 1.99x
Net debt/EBITDA 5.75x
Stability
37 /100
Moderate Rev. volatility 17.97%
EPS volatility 73.84%
Profitable years 4
Întreabă StockBot despre ORCHPHARMA.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Dhanuka
Employees
871
Headquarters
Narsinghpur
Evenimente viitoare
16 NOV.
Earnings
Upcoming earnings report